Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Data from BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression
Home
Publications
Data from BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression
Data from BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression
Authors:
LX
Lijie Xing
Lijie Xing
SW
Su Wang
Su Wang
Jiye Liu
Jiye Liu
TY
Tengteng Yu
Tengteng Yu
HC
Hailin Chen
Hailin Chen
KW
Kenneth Wen
Kenneth Wen
YL
Yuyin Li
Yuyin Li
LL
Liang Lin
Liang Lin
PH
Phillip A. Hsieh
Phillip A. Hsieh
SC
Shih-Feng Cho
Shih-Feng Cho
GA
Gang An
Gang An
LQ
Lugui Qiu
Lugui Qiu
See more
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
31 March 2023
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/1078-0432.c.6530600.v1
Abstract
No abstract available
Keywords
DARATUMUMAB
Scroll to top